Christoph Hoenke

This inventor holds 69 USPTO granted patents and 11 published patent applications, plus 11 CIPO patents and 40 EPO patents, primarily in CCR2 Receptor Antagonists (CPC class C07D). Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Kg, Centrexion Therapeutics Corporation. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Hoenke. Retrieved from https://idiyas.com/inventor/christoph-hoenke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 69 (Patent Applications = 11)

% Patents Active = 97.1

CIPO Patents = 11 (Patent Applications = 6)

EPO Patents = 40 (Patent Applications = 34)

Average Co-Inventor Count = 7.2

ph-index = 9

Forward Citations = 317(Granted Patents)

Forward Citations (Not Self Cited) = 208(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Ingelheim, DE (2002 - 2014)
Ingelheim am Rhein, DE (2000 - 2015)
Biberach, DE (2015)
Biberach an der Riss, DE (2014 - 2024)

Company Filing History:

54 out of 1,562

Boehringer Ingelheim International Gmbh

patents

6 out of 149

Boehringer Ingelheim Pharma Kg

patents

5 out of 36

Centrexion Therapeutics Corporation

patents

4. 4 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

CCR2 Receptor Antagonists

Cyclic Ether Derivatives

Pyrazole Compounds

Ghrelin O-Acyl Transferase Inhibitors

Piperazino-Dihydrothienopyrimidines

Thiazolyl-Dihydro-Quinazolines

Inflammatory Diseases

Pyridine Derivatives

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433897 - Pyridine derivatives with n-linked cyclic substituents as cGAS inhibitors (2025-10-07),

2. 12351584 - Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide (2025-07-08),

3. 12209094 - CCR2 receptor antagonists and uses thereof (2025-01-28),

4. 12043625 - Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitors (2024-07-23),

5. 11731981 - CCR2 receptor antagonists and uses thereof (2023-08-22),

6. 11691977 - Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide (2023-07-04),

7. 11583532 - Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (GOAT) inhibitors (2023-02-21),

8. 11254688 - Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors (2022-02-22),

9. 11046706 - CCR2 receptor antagonists and uses thereof (2021-06-29),

10. 10875867 - Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide (2020-12-29),

11. 10479794 - Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide (2019-11-19),

12. 10307402 - Azabenzimidazole derivatives as agonists of the AMP-activated protein kinase (2019-06-04),

13. 10196402 - CCR2 receptor antagonists and uses thereof (2019-02-05),

14. 10023575 - Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide (2018-07-17),

15. 9670222 - CCR2 receptor antagonists and uses thereof (2017-06-06),

Title: Christoph Hoenke: A Trailblazer in Innovation

Introduction: Christoph Hoenke, a visionary inventor in the field of technology, has left an indelible mark with his groundbreaking contributions. His dedication to pushing the boundaries of what is possible has shaped the world of patents and inventions significantly.

Latest Patents:

1. CCR2 Receptor Antagonists and Uses Thereof: Christoph Hoenke's innovative work in developing novel antagonists for CCR2 has opened new doors for treating pulmonary diseases like asthma and COPD.

2. Cyclic Ether Derivatives of Pyrazolo[1,5-A]pyrimidine-3-Carboxyamide: His invention of spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide has proven to be invaluable in treating central nervous system diseases and other related conditions.

Career Highlights: With an impressive portfolio of 65 patents, Christoph Hoenke has made significant strides in the technology industry. His intellectual prowess and inventive spirit have earned him recognition as a leading figure in the field.

Collaborations: Throughout his career, he has worked with esteemed colleagues such as Riccardo Giovannini and Stefan Scheuerer. His collaborations have not only enhanced the quality of his work but have also fostered a culture of innovation and excellence.

Conclusion: Christoph Hoenke's relentless pursuit of innovation and his remarkable contributions to the field of technology make him a true pioneer. His work serves as an inspiration for aspiring inventors, urging them to strive for greatness and make a lasting impact on the world of patents and inventions.Dot

Profile summary based on public USPTO records.